Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial. [electronic resource]
Producer: 20091203Description: 1661-8.e1-2 p. digitalISSN:- 1528-0012
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Cysts -- drug therapy
- Double-Blind Method
- Female
- Humans
- Liver Diseases -- drug therapy
- Liver Function Tests
- Male
- Middle Aged
- Organ Size
- Peptides, Cyclic -- therapeutic use
- Polycystic Kidney, Autosomal Dominant -- complications
- Quality of Life
- Somatostatin -- analogs & derivatives
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.